Ichiro Nakano MD, PhD

Ichiro Nakano MD, PhD
Assoc ProfessorCollege of Medicinenakano.10@osu.edu
Wiseman Hall 400 W 12th Avenue Columbus Ohio 43210
Phone:Fax: 614-688-4882
  • Experimental Therapeutics

Research Description

Dr. Nakano's lab seeks to develop novel and effective therapeutics for malignant brain tumors. Projects include drug screening, structure-based drug design, establishment of patient-derived cancer stem cells, and collection and evaluation of clinical samples of brain cancers including tumor specimens, blood samples, and cerebrospinal fluids. These samples are widely shared nationally and internationally by establishing collaboration.

Current Publications

  • Godlewski JExtracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.Cancer Res 74 738-50 2/1/2014
  • Rich JNHigh-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.Cell Rep 6 117-29 1/16/2014
  • Penalva LOGenomic Analyses Reveal Broad Impact of miR-137 on Genes Associated with Malignant Transformation and Neuronal Differentiation in Glioblastoma Cells.PLoS One 9 e85591 1/1/2014
  • Flavahan WA, Wu Q, Hitomi M, Rahim N, Kim Y, Sloan AE, Weil RJ, Nakano I, Sarkaria JN, Stringer BW, Li M, Lathia JD, Rich JN, Hjelmeland ABBrain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.Nat Neurosci 16(10) 1373-82 10/1/2013
  • Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, Raj D, Kodama Y, Raghunathan A, Olar A, Joshi K, Pelloski CE, Heimberger A, Kim SH, Cahill DP, Rao G, Den Dunnen WF, Boddeke HW, Phillips HS, Nakano I, Lang FF, Colman H, Sulman EP, Aldape KMesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.Cancer Cell 24(3) 331-46 9/9/2013
  • Peruzzi P, Bronisz A, Nowicki MO, Wang Y, Ogawa D, Price R, Nakano I, Kwon CH, Hayes J, Lawler SE, Ostrowski MC, Chiocca EA, Godlewski JMicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.Neuro Oncol 15(9) 1212-24 9/1/2013
  • Joshi K, Banasavadi-Siddegowda Y, Mo X, Kim SH, Mao P, Kig C, Nardini D, Sobol RW, Chow LM, Kornblum HI, Waclaw R, Beullens M, Nakano IMELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.Stem Cells 31(6) 1051-63 6/1/2013
  • Mao P, Joshi K, Li J, Kim SH, Li P, Santana-Santos L, Luthra S, Chandran UR, Benos PV, Smith L, Wang M, Hu B, Cheng SY, Sobol RW, Nakano IMesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.Proc Natl Acad Sci U S A 110(21) 8644-9 5/21/2013
  • Gu C, Banasavadi-Siddegowda YK, Joshi K, Nakamura Y, Kurt H, Gupta S, Nakano ITumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.Stem Cells 31(5) 870-81 5/1/2013
  • Guvenc H, Pavlyukov MS, Joshi K, Kurt H, Banasavadi-Siddegowda YK, Mao P, Hong C, Yamada R, Kwon C, Bhasin D, Chettiar S, Kitange G, Park IH, Sarkaria JN, Li C, Shakhparonov MI, Nakano IImpairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex.Clin Cancer Res 19(3) 631-42 2/1/2013
  • Jin X, Jin X, Sohn YW, Yin J, Kim SH, Joshi K, Nam DH, Nakano I, Kim HBlockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression.Cancer Lett 328(2) 235-42 1/28/2013
  • Ammirati M, Theeb Lamki T, Brian Shaw A, Forde B, Nakano I, Mani MA streamlined protocol for the use of the semi-sitting position in neurosurgery: a report on 48 consecutive procedures.J Clin Neurosci 20(1) 32-4 1/1/2013
  • Smith L, Nakano IFluorescence-guided brain tumor surgery.World Neurosurg 78(6) 559-64 12/1/2012
  • Lathia JD, Li M, Hall PE, Gallagher J, Hale JS, Wu Q, Venere M, Levy E, Rani MR, Huang P, Bae E, Selfridge J, Cheng L, Guvenc H, McLendon RE, Nakano I, Sloan AE, Phillips HS, Lai A, Gladson CL, Bredel M, Bao S, Hjelmeland AB, Rich JNLaminin alpha 2 enables glioblastoma stem cell growth.Ann Neurol 72(5) 766-78 11/1/2012
  • Robles Irizarry L, Hambardzumyan D, Nakano I, Gladson CL, Ahluwalia MSTherapeutic targeting of VEGF in the treatment of glioblastoma.Expert Opin Ther Targets 16(10) 973-84 10/1/2012
  • Nakano I, Chiocca AEHope and challenges for dendritic cell-based vaccine therapy for glioblastoma.World Neurosurg 77(5-6) 633-5 5/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu